PURPOSE: Li-Fraumeni syndrome (LFS) is associated with p53 germline mutations, and carriers are at increased risk for multiple primary cancers. We evaluated outcomes following the administration of a video-based decision aid (DA) prior to clinical p53 genetic counseling and testing among persons who had previously participated in cancer genetics research. METHODS: Fifty-seven individuals at risk for a known p53 mutation completed baseline and post-DA measures of psychological outcomes, plus knowledge and attitudes regarding p53 genetic testing. Counseling and testing uptake also was recorded. RESULTS: At baseline, multivariate analysis showed that greater testing intention was associated with lower decisional conflict (P < 0.01). Compared with baseline data, multivariate analyses of post-DA outcomes showed that knowledge about LFS and genetic testing increased and decisional conflict related to testing decreased (P < 0.001). Mean cancer worries scores decreased among all participants (P < 0.001), and mean depression scores decreased for males (P < 0.05). Thirty-nine (68%) completed pre-test genetic counseling and 23 (40%) subsequently gave a blood sample for clinical genetic testing. CONCLUSION: This intervention was useful as an initial outreach and educational method for families considering p53 genetic testing, and may improve knowledge about LFS as well as psychological outcomes.
PURPOSE: Li-Fraumeni syndrome (LFS) is associated with p53 germline mutations, and carriers are at increased risk for multiple primary cancers. We evaluated outcomes following the administration of a video-based decision aid (DA) prior to clinical p53 genetic counseling and testing among persons who had previously participated in cancer genetics research. METHODS: Fifty-seven individuals at risk for a known p53 mutation completed baseline and post-DA measures of psychological outcomes, plus knowledge and attitudes regarding p53 genetic testing. Counseling and testing uptake also was recorded. RESULTS: At baseline, multivariate analysis showed that greater testing intention was associated with lower decisional conflict (P < 0.01). Compared with baseline data, multivariate analyses of post-DA outcomes showed that knowledge about LFS and genetic testing increased and decisional conflict related to testing decreased (P < 0.001). Mean cancer worries scores decreased among all participants (P < 0.001), and mean depression scores decreased for males (P < 0.05). Thirty-nine (68%) completed pre-test genetic counseling and 23 (40%) subsequently gave a blood sample for clinical genetic testing. CONCLUSION: This intervention was useful as an initial outreach and educational method for families considering p53 genetic testing, and may improve knowledge about LFS as well as psychological outcomes.
Authors: Katherine A Schneider; Lisa M DiGianni; Andrea Farkas Patenaude; Neil Klar; Jill E Stopfer; Kathleen A Calzone; Frederick P Li; Barbara L Weber; Judy E Garber Journal: Genet Test Date: 2004
Authors: C Lerman; B Biesecker; J L Benkendorf; J Kerner; A Gomez-Caminero; C Hughes; M M Reed Journal: J Natl Cancer Inst Date: 1997-01-15 Impact factor: 13.506
Authors: Michael J Green; Susan K Peterson; Maria Wagner Baker; Gregory R Harper; Lois C Friedman; Wendy S Rubinstein; David T Mauger Journal: JAMA Date: 2004-07-28 Impact factor: 56.272
Authors: K Tiller; B Meiser; E Reeson; M Tucker; L Andrews; C Gaff; J Kirk; K A Phillips; M Friedlander Journal: Int J Gynecol Cancer Date: 2003 Jan-Feb Impact factor: 3.437
Authors: A N Freedman; L Wideroff; L Olson; W Davis; C Klabunde; K P Srinath; B B Reeve; R T Croyle; R Ballard-Barbash Journal: Am J Med Genet A Date: 2003-07-01 Impact factor: 2.802
Authors: A Chompret; L Brugières; M Ronsin; M Gardes; F Dessarps-Freichey; A Abel; D Hua; L Ligot; M G Dondon; B Bressac-de Paillerets; T Frébourg; J Lemerle; C Bonaïti-Pellié; J Feunteun Journal: Br J Cancer Date: 2000-06 Impact factor: 7.640
Authors: M S van Roosmalen; P F M Stalmeier; L C G Verhoef; J E H M Hoekstra-Weebers; J C Oosterwijk; N Hoogerbrugge; U Moog; W A J van Daal Journal: Br J Cancer Date: 2004-01-26 Impact factor: 7.640
Authors: Corinna L Schultz; Melissa A Alderfer; Robert B Lindell; Zachary McClain; Kristin Zelley; Kim E Nichols; Carol A Ford Journal: J Genet Couns Date: 2018-06-16 Impact factor: 2.537
Authors: Susan K Peterson; Rebecca D Pentz; Salma K Marani; Patricia A Ward; Amie M Blanco; Denise LaRue; Kristen Vogel; Tamara Solomon; Louise C Strong Journal: Psychooncology Date: 2008-08 Impact factor: 3.955
Authors: Saskia C Sanderson; Sabrina A Suckiel; Micol Zweig; Erwin P Bottinger; Ethylin Wang Jabs; Lynne D Richardson Journal: Genet Med Date: 2015-09-03 Impact factor: 8.822